Renaissance Technologies’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
IC
YCM
EAM
VA
BFM
Renaissance Technologies's PASG Position: Q2 2026 in Review
Renaissance Technologies reduced its Passage Bio (PASG) stake by 64% in Q2 2026, selling an estimated $536K and leaving 47,892 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #2845.
Renaissance Technologies first reported a position in PASG in Q3 2020 and has held it in 22 quarters since. The position peaked at $3.02M in Q4 2021. 30 funds tracked by Wall St. Rank hold PASG as of Q2 2026.
- Renaissance Technologies held 47,892 shares of Passage Bio worth $234K as of Q2 2026.
- Renaissance Technologies sold 85,720 Passage Bio shares in Q2 2026, an estimated $536K.
- Passage Bio made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2845 holding.
- Renaissance Technologies first reported a position in Passage Bio in Q3 2020 and has held it in 22 quarters since.
- Renaissance Technologies's Passage Bio position peaked at $3.02M in Q4 2021.
- 30 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.